GlaxoSmithKline Receives FDA Approval for Renal Cancer Treatment - Seeking Alpha (blog) PDF Print
Seeking Alpha (blog)... the US Food and Drug Administration's (FDA) approval of Votrient (pazopanib) for the treatment of patients with advanced renal cell carcinoma (RCC),

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.